James Wassil
Chief Operating Officer bij VAXCYTE, INC.
Vermogen: 15 M $ op 31-03-2024
Actieve functies van James Wassil
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VAXCYTE, INC. | Chief Operating Officer | 01-12-2019 | - |
Loopbaan van James Wassil
Eerdere bekende functies van James Wassil
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ICOSAVAX, INC. | Director/Board Member | 01-06-2022 | 19-02-2024 |
Independent Dir/Board Member | 01-06-2022 | 19-02-2024 | |
PFIZER, INC. | Corporate Officer/Principal | 01-05-2015 | 01-12-2019 |
NOVARTIS AG | Corporate Officer/Principal | 01-08-2008 | 01-05-2015 |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - | - |
MERCK & CO., INC. | Sales & Marketing | - | - |
Opleiding van James Wassil
University of Notre Dame | Undergraduate Degree |
Lehigh University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Zwitserland | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
PFIZER, INC. | Health Technology |
NOVARTIS AG | Health Technology |
VAXCYTE, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
Icosavax, Inc.
Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- James Wassil
- Ervaring